Menu Close

Articles on Nanotechnology

Displaying 1 - 20 of 138 articles

The course of nanotechnology, like the carbon nanotubes in this laboratory, has been guided by many stakeholders. VCG/VCG via Getty Images

Navigating the risks and benefits of AI: Lessons from nanotechnology on ensuring emerging technologies are safe as well as successful

Two decades ago, the nanotechnology revolution avoided stumbling by bringing a wide range of people to the table to chart its development. The window is closing fast on AI following suit.
Identifying the commonalities between cardiovascular disease and cancer could lead to improved treatments for both. Sveta Zi/iStock via Getty Images Plus

Could a single drug treat the two leading causes of death in the US: cancer and cardiovascular disease?

Cardiovascular disease and cancer share many parallels in their origins and how they develop. Nanoparticles offer one potential way to effectively treat both with reduced side effects.
Nanoparticles (white disks) can be used to deliver treatment to cells (blue). Brenda Melendez and Rita Serda/National Cancer Institute, National Institutes of Health

Nanomedicines for various diseases are in development – but research facilities produce vastly inconsistent results on how the body will react to them

The proteins that cover nanoparticles are essential to understanding how they work in the body. Across 17 proteomics facilities in the US, less than 2% of the identified proteins were identical.
Nanoparticles can help cancer drugs home in on tumors and avoid damaging healthy cells. Kateryna Kon/Science Photo Library via Getty Images

Nanoparticles are the future of medicine – researchers are experimenting with new ways to design tiny particle treatments for cancer

The COVID-19 mRNA vaccines put nanomedicine in the spotlight as a potential way to treat diseases like cancer and HIV. While the field isn’t there yet, better design could help fulfill its promise.
We interact with nanoparticles in multiple ways every day. The nanoparticles in this illustration are delivering drugs to cells. (Shutterstock)

The nanoparticles in mRNA vaccines are nothing to fear: We interact with many useful, tiny particles every day

Some vaccine hesitancy is based on a fear of the nanoparticles used in mRNA vaccines. But humans have been interacting with nanoparticles for millennia, and we use nanotechnology-based devices every day.

Top contributors

More